Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Nov;78(11):1286-7.
doi: 10.1136/jnnp.2007.115774.

A novel founder mutation in the MFN2 gene associated with variable Charcot-Marie-Tooth type 2 phenotype in two families from Southern Italy

A novel founder mutation in the MFN2 gene associated with variable Charcot-Marie-Tooth type 2 phenotype in two families from Southern Italy

M Muglia et al. J Neurol Neurosurg Psychiatry. 2007 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

Similar articles

Cited by

References

    1. Züchner S, Mersiyanova I V, Muglia M.et al Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot–Marie–Tooth neuropathy type 2A. Nat Genet 200436449–451. - PubMed
    1. Verhoeven K, Claeys K G, Zuchner S.et al MFN2 mutation distribution and genotype/phenotype correlation in Charcot–Marie–Tooth type 2. Brain 20061292093–2102. - PubMed
    1. Chung K W, Kim S B, Park K D.et al Early onset severe and late‐onset mild Charcot–Marie–Tooth disease with mitofusin 2 (MFN2) mutations. Brain 20061292103–2118. - PubMed
    1. Engelfried K, Vorgerd M, Hagedorn M.et al Charcot–Marie–Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2). BMC Med Genet 2006753 - PMC - PubMed
    1. Lawson V H, Graham B V, Flanigan K M. Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene. Neurology 200565197–204. - PubMed

Publication types